Prime Medicine (PRME) Insider Trading & Ownership $1.96 -0.07 (-3.20%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Prime Medicine (NYSE:PRME) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.47%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$20 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$3.68 M Get PRME Insider Trade Alerts Want to know when executives and insiders are buying or selling Prime Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PRME Insider Buying and Selling by Quarter Remove Ads Prime Medicine Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/15/2024Robert NelsenDirectorBuy3,200,000$6.25$20,000,000.00 6/20/20232019 Gp L.L.C. GvMajor ShareholderSell37,405$15.06$563,319.30 6/16/20232019 Gp L.L.C. GvMajor ShareholderSell6,532$15.02$98,110.64 6/14/20232019 Gp L.L.C. GvMajor ShareholderSell28,960$14.87$430,635.20 6/12/20232019 Gp L.L.C. GvMajor ShareholderSell16,031$14.98$240,144.38 6/9/20232019 Gp L.L.C. GvMajor ShareholderSell15,672$14.48$226,930.56 6/5/20232019 Gp L.L.C. GvMajor ShareholderSell22,434$16.70$374,647.80 5/31/20232019 Gp L.L.C. GvMajor ShareholderSell16,633$13.65$227,040.45 5/26/20232019 Gp L.L.C. GvMajor ShareholderSell12,602$13.70$172,647.40 5/24/20232019 Gp L.L.C. GvMajor ShareholderSell7,900$13.66$107,914.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/22/20232019 Gp L.L.C. GvMajor ShareholderSell87,922$14.13$1,242,337.86 (Data available from 1/1/2013 forward) PRME Insider Trading Activity - Frequently Asked Questions Who is on Prime Medicine's Insider Roster? The list of insiders at Prime Medicine includes 2019 Gp L.L.C. Gv, and Robert Nelsen. Learn more on insiders at PRME. What percentage of Prime Medicine stock is owned by insiders? 23.47% of Prime Medicine stock is owned by insiders. Learn more on PRME's insider holdings. Which Prime Medicine insiders have been buying company stock? The following insider purchased PRME shares in the last 24 months: Robert Nelsen ($20,000,000.00). How much insider buying is happening at Prime Medicine? Insiders have purchased a total of 3,200,000 PRME shares in the last 24 months for a total of $20,000,000.00 bought. Which Prime Medicine insiders have been selling company stock? The following insider sold PRME shares in the last 24 months: 2019 Gp L.L.C. Gv ($3,683,727.59). How much insider selling is happening at Prime Medicine? Insiders have sold a total of 252,091 Prime Medicine shares in the last 24 months for a total of $3,683,727.59 sold. Prime Medicine Key ExecutivesDr. Keith Michael Gottesdiener M.D. (Age 70)Ph.D., President, CEO, Secretary & Director Compensation: $1.06MDr. Ann L. Lee Ph.D. (Age 62)Chief Technical Officer Compensation: $684.78kDr. Jeremy S. Duffield M.D. (Age 56)Ph.D., Chief Scientific Officer Compensation: $680.65kDr. Andrew Anzalone M.D. (Age 37)Ph.D., Co-Founder & Head of Prime Editing Platform Dr. David R. Liu Ph.D.Co-Founder & Chair of Scientific Advisory BoardDr. Allan Reine M.D. (Age 49)Chief Financial Officer Dr. Meredith Goldwasser (Age 53)Senior VP and Head of Strategy & Corporate Operations Ms. Carman Alenson CPA (Age 58)M.B.A., Senior VP of Finance & Chief Accounting Officer Dr. Karen Brown J.D.Ph.D., Senior Vice President of Intellectual Property & Legal AffairsMs. Niamh AlixChief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies Xencor Insider Trades Replimune Group Insider Trades Phibro Animal Health Insider Trades Day One Biopharmaceuticals Insider Trades Zymeworks Insider Trades Evolus Insider Trades Avadel Pharmaceuticals Insider Trades Cogent Biosciences Insider Trades Avid Bioservices Insider Trades uniQure Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NYSE:PRME) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prime Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRME Stock Free PRME Stock Alerts